Analysts' Actions: CTRX EV MYL STT ITMN

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Actuate (BIRT) was downgraded to hold at TheStreet Ratings.

Catamaran (CTRX) was downgraded at ISI Group to neutral from buy. Twelve-month price target is $50. Company's profit outlook is going through a transition period, ISI Group said.

Endologix (ELGX) was downgraded at Oppenheimer to outperform from perform. Twelve-month price target is $16. Domestic business is facing increased competition, Oppenheimer said.

Eaton Vance (EV) was upgraded at Sterne Agee to buy from neutral. Valuation call, as headwinds could be nearing a bottom, Sterne Agee said.

Intermune (ITMN) was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a 12-month price target of $33, Credit Suisse said.

M/I Homes (MHO) was downgraded to hold at TheStreet Ratings.

Mylan (MYL) was downgraded at Needham to hold from buy. Valuation call, as the stock is up 36% year to date, Needham said.

NCI Building Systems (NCS) was initiated at UBS with a buy rating. Strong leverage to a nonresidential construction recovery, UBS said. Twelve-month price target is $21. Buy rating.

State Street (STT) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $68. Estimates were also cut, given lower sales and higher expected costs, RBC Capital said.

Westlake (WLK) was upgraded at J.P. Morgan to overweight from neutral.

Stock Comments / EPS Changes

American Airlines ( AAL) price target was raised at UBS. Large cost-savings plans to come, UBS said. Twelve-month price target is $37. Neutral rating.

Alkermes (ALKS) price target was raised at UBS. Driven by manufacturing and royalty revenue, UBS said. Twelve-month price target is $53. Neutral rating.

Deckers (DECK) estimates, price target were raised at Credit Suisse. Twelve-month price target is now $61. Estimates were also increased, given higher demand across the board, Credit Suisse said. Underperform rating.

Foster Wheeler (FWLT) price target, EPS estimates were increased at UBS. E&C bookings are healthy, and Power bookings are better than expected, UBS said. Twelve-month price target is $33. Neutral rating.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

3 Great Stocks for Retirees to Own

3 Great Stocks for Retirees to Own

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019